Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.770
-0.080 (-4.32%)
At close: Mar 9, 2026, 4:00 PM EDT
1.770
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:49 PM EDT
Lineage Cell Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 441 | 405 | 111 | 191 | 199 | 413 | |
| Market Cap Growth | 236.30% | 265.38% | -41.93% | -4.09% | -51.84% | 56.44% | |
| Enterprise Value | 388 | 366 | 79 | 151 | 134 | 349 | |
| Last Close Price | 1.77 | 1.67 | 0.50 | 1.09 | 1.17 | 2.45 | |
| PS Ratio | 30.29 | 27.80 | 11.66 | 21.32 | 13.53 | 95.13 | |
| PB Ratio | 9.66 | 9.34 | 1.44 | 3.08 | 2.77 | 4.54 | |
| P/TBV Ratio | 202.52 | 185.89 | 5.23 | 30.84 | 12.45 | 11.89 | |
| P/FCF Ratio | - | - | - | - | 307.85 | - | |
| P/OCF Ratio | - | - | - | - | 187.79 | - | |
| EV/Sales Ratio | 26.62 | 25.12 | 8.36 | 16.88 | 9.11 | 80.50 | |
| EV/FCF Ratio | - | - | - | - | 207.31 | - | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.03 | 0.05 | 0.05 | 0.03 | |
| Debt / FCF Ratio | - | - | - | - | 6.03 | - | |
| Net Debt / Equity Ratio | -1.23 | -1.23 | -0.59 | -0.52 | -0.75 | -0.61 | |
| Net Debt / EBITDA Ratio | 2.53 | 2.53 | 2.17 | 1.59 | 2.48 | 1.15 | |
| Net Debt / FCF Ratio | 2.75 | 2.75 | 1.91 | 1.11 | -83.56 | 2.32 | |
| Asset Turnover | 0.13 | 0.13 | 0.09 | 0.08 | 0.10 | 0.03 | |
| Quick Ratio | 5.05 | 5.05 | 3.47 | 2.02 | 3.07 | 2.32 | |
| Current Ratio | 5.20 | 5.20 | 3.65 | 2.14 | 3.16 | 2.37 | |
| Return on Equity (ROE) | -105.30% | -105.30% | -26.73% | -32.07% | -32.37% | -46.52% | |
| Return on Assets (ROA) | -12.06% | -12.06% | -12.53% | -11.80% | -9.44% | -21.77% | |
| Return on Capital Employed (ROCE) | -21.50% | -21.50% | -21.60% | -25.50% | -21.50% | -38.60% | |
| Earnings Yield | -14.41% | -15.70% | -16.80% | -11.27% | -13.21% | -10.42% | |
| FCF Yield | -4.41% | -4.80% | -21.36% | -15.33% | 0.33% | -5.79% | |
| Buyback Yield / Dilution | -14.95% | -14.95% | -15.94% | -1.69% | -3.22% | -9.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.